Mumbai: PB Fintech, the parent company of Policybazaar, could face a significant earnings reset if proposed changes to India’s insurance distribution framework are implemented in their most adverse form, according to Bernstein. The brokerage estimates that the company’s FY30 profit could be reduced by about 38% under its “max pain” scenario.
Despite the potential earnings hit, Bernstein has retained its ‘Outperform’ rating on PB Fintech and a target price of Rs 2,310 per share. Based on the stock’s Friday closing price, the target implies more than 98% potential upside, according to a September 28 report.
The assessment comes after PB Fintech shares suffered a sharp sell-off following the Insurance Regulatory and Development Authority of India’s (IRDAI) consultation paper proposing changes to insurance distribution commissions and related expense structures. The stock fell more than 38% over two sessions before rebounding in early trade on Monday.
FY30 profit estimate cut to Rs 20 billion
Analysts Manas Agrawal and Himank Sangai estimate PB Fintech’s FY30 profit at around Rs 20 billion under Bernstein’s adverse scenario, compared with an earlier estimate of about Rs 32 billion before the proposed regulatory changes.
That represents a substantial reduction in the brokerage’s earnings expectations. However, Bernstein expects the company to offset part of the initial pressure through cost optimisation before returning to growth and margin expansion from a lower base.
The brokerage’s scenario assumes that the proposed regulatory framework will materially change the economics of insurance distribution, particularly for digital platforms that rely heavily on commissions and customer acquisition.
The proposed framework is still under consultation and has not become final regulation. IRDAI has sought feedback from stakeholders on the draft proposals.
Health and motor insurance face the biggest pressure
Bernstein’s analysis suggests that PB Fintech’s insurance take rates could decline by around 40% if the proposals are implemented in their most adverse form.
The health and motor insurance businesses are expected to face the greatest pressure because of their reliance on distribution commissions and the proposed changes to the economics of selling these products.
The IRDAI consultation paper proposes changes to commission structures based on product complexity and the effort involved in selling and servicing policies. It also proposes lower commission levels for products distributed through open-architecture channels such as brokers and banks.
For health insurance, the proposals include caps on commissions for new policies and lower limits for renewals and portability. Motor insurance commissions would also face proposed limits.
These changes could affect PB Fintech’s revenue generation from insurance distribution if the final framework broadly follows the consultation paper.
FY28 could become a transition year
Bernstein expects FY28 to be a year of “rational growth” for PB Fintech as the company prioritises profitability and adjusts its cost structure to the new regulatory environment.
The brokerage’s scenario assumes a roughly 40% reduction in insurance take rates, along with a lower premium-growth assumption.
PB Fintech management has indicated that it can rationalise several growth-linked expenses if the proposed framework affects the economics of its business. These include call-centre hiring, variable payouts and performance-marketing expenses.
The company could therefore slow spending in areas that were previously supporting rapid customer and premium growth.
Bernstein expects direct costs associated with the core business to decline meaningfully as growth spending is reduced. It also factors in phased reductions in indirect costs through FY28 and FY29.
FY28 profit could fall to Rs 11 billion
The near-term earnings impact could nevertheless be substantial.
Bernstein estimates that PB Fintech’s FY28 profit after tax could decline by around 34% from its earlier forecast under the adverse scenario. The brokerage sees FY28 profit at approximately Rs 11 billion, compared with an estimated FY27 profit of around Rs 12.5 billion.
This would make FY28 an important transition period for the company.
The brokerage expects the earnings trajectory to improve from FY29 as PB Fintech gradually resumes growth spending and adapts its business model to the changed commission environment.
By FY30, profit is estimated to recover to around Rs 20 billion in Bernstein’s scenario, although that would remain substantially below the earlier Rs 32 billion estimate.
Lower customer prices could support volumes
The impact of lower commissions may not be entirely negative for insurance distribution.
If distributors and insurers pass some of the savings from lower commissions to customers through reduced pricing, demand and policy volumes could increase. Bernstein therefore expects higher volumes to provide some offset to the reduction in take rates.
PB Fintech management has also indicated that the company could respond to the proposed changes by reducing costs and developing additional revenue streams.
Separately, industry analysts have noted that lower distribution costs could eventually support higher insurance volumes, although the transition could be difficult for businesses whose existing unit economics depend heavily on commissions.
PB Fintech may explore new business models
The proposed changes could also push PB Fintech towards a broader insurance business model.
The company has indicated that it may explore options including manufacturing insurance products and other asset-light opportunities. Business Standard reported that PB Fintech could consider seeking an insurance licence as it evaluates the impact of the proposed commission changes on its distribution business.
Bernstein expects the company to explore ways of monetising its health insurance franchise through structures such as managing general agent (MGA) or corporate agent arrangements, or potentially move towards an insurance manufacturing model.
Such moves could reduce the company’s dependence on the traditional commission-based distribution model, although they would also involve changes to its business structure and economics.
Regulatory proposal triggered sharp stock-market reaction
The market reaction to the IRDAI consultation paper has already been severe.
PB Fintech shares fell nearly 36% in a single session on September 24, after the regulator’s proposals raised concerns about the future economics of insurance distribution.
Moneycontrol reported that the stock fell 34% to Rs 1,244.50 on September 24, while another report said the shares had lost more than 38% over two sessions.
On Monday, September 28, the stock staged a partial recovery. PB Fintech shares rose as much as 4.13% to Rs 1,213.70 on the BSE in early trade, with the rebound attributed to short-covering and value buying following the sharp decline.
Bernstein remains positive despite earnings risk
Bernstein’s stance highlights the difference between the brokerage’s near-term earnings expectations and its longer-term valuation view.
Under the maximum-impact scenario, the proposed rules could significantly reduce take rates, revenue and near-term profitability. However, Bernstein believes cost optimisation can cushion some of the initial impact and that growth and margins could recover from a lower base from FY29 onwards.
The brokerage has therefore retained its ‘Outperform’ rating and Rs 2,310 target price. The target is Bernstein’s stated valuation view and should not be interpreted as a guaranteed future price level.
For investors tracking PB Fintech, the key variables will now include the final form of the IRDAI regulations, the company’s ability to adjust costs, premium-volume growth, insurance take rates and its potential expansion into new insurance business models.
Conclusion
PB Fintech faces a potentially significant change in its earnings profile if the proposed insurance distribution framework is implemented along the lines assumed in Bernstein’s adverse scenario. The brokerage estimates a 38% reduction in its FY30 profit forecast, from Rs 32 billion to around Rs 20 billion.
At the same time, Bernstein expects cost controls, potential volume gains and new business opportunities to help the company adjust. With the regulatory framework still under consultation, the eventual impact will depend on the final rules and how PB Fintech and the wider insurance industry adapt to them.